Lv1
16 积分 2024-11-21 加入
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies
1个月前
已完结
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
1个月前
已完结
Effects of once‐daily teneligliptin on 24‐h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4‐week, randomized, double‐blind, placebo‐controlled trial
1个月前
已完结
Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis
1个月前
已完结
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders
2个月前
已完结
AAPM&R consensus guidance on spasticity assessment and management
6个月前
已完结
Epidemiological features of traumatic spinal cord injury in China: A systematic review and meta-analysis
7个月前
已完结
Safety and effectiveness of candesartan and candesartan/HCT fixed dose combination in patients with hypertension
11个月前
已关闭
Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide
11个月前
已完结
Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care
11个月前
已完结
皖公网安备34019202002308
